New drug trial offers hope for adults stuck in cycle of kidney disease relapses
NCT ID NCT07233330
Summary
This trial is testing whether a drug called obinutuzumab can help adults with a specific type of kidney disease (idiopathic nephrotic syndrome) that keeps coming back and currently depends on another drug, rituximab. The study will enroll 10 adult participants to see if obinutuzumab is safe, effective, and can keep them relapse-free for longer. Researchers believe this newer drug may work better by more thoroughly depleting certain immune cells thought to drive the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEPHROTIC SYNDROME，IDIOPATHIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Research Centre for Rare Diseases Aldo e Cele Daccò
Ranica, BG, 24020, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.